Showing 2,501 - 2,520 results of 152,992 for search '(( a we decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.94s Refine Results
  1. 2501
  2. 2502
  3. 2503
  4. 2504

    Prey establishment and decrease in inter-population contacts protects T6SS sensitive lineages. by Marta Rudzite (15991136)

    Published 2023
    “…Representative simulation outputs showing how decrease in initial bacterial density (<b>C</b>) or changes in strain mixing ratio (<b>E</b>) within initial population promotes prey (red) survival in a mix attacker population (green) with differing mean of T6SS firing rate and within a context of highly lytic toxins. …”
  5. 2505

    MAP-2 decrease follows the early PSA-NCAM reduction induced by glutamate exposure. by María Fernanda Podestá (639243)

    Published 2014
    “…<p>Hippocampal neurons in culture (DIV 12–13) were briefly exposed to 5 µM glutamate and evaluated 1, 3, 6 and 12 h later. …”
  6. 2506

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  7. 2507

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  8. 2508

    AS021 activity and Satb2 expression decrease within deep layers at postnatal stages. by Kensuke Tashiro (193459)

    Published 2011
    “…A similar decrease is observed for βgal, confirming the specificity of the AS021 activity. …”
  9. 2509

    Glycomic Analysis Reveals a Conserved Response to Bacterial Sepsis Induced by Different Bacterial Pathogens by Daniel W. Heindel (1321224)

    Published 2022
    “…Bisecting GlcNAc was decreased upon sepsis and a strong increase in core 1/3 <i>O</i>-glycans was observed. …”
  10. 2510

    Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera by Angela Bozza (8908091)

    Published 2023
    “…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”
  11. 2511
  12. 2512
  13. 2513
  14. 2514
  15. 2515

    A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

    Published 2019
    “…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”
  16. 2516
  17. 2517
  18. 2518
  19. 2519
  20. 2520